Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy.

Current oncology (Toronto, Ont.)(2022)

引用 2|浏览28
暂无评分
摘要
MLR emerged as an independent predictive factor for PFS and OS in treatment-naive unresectable ESCC patients treated with chemoimmunotherapy. The constructed nomogram of MLR and clinical parameters was a reliable model for prognostic estimation.
更多
查看译文
关键词
PD-1/PD-L1,esophageal squamous cell carcinoma,immunotherapy,monocyte-to-lymphocyte ratio,nomogram
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要